| http://dbpedia.org/ontology/abstract
|
アザプロパゾン(Azapropazone)は、Goldshield社がRheumoxの商標名で製造する非ステロイド性抗炎症薬である。 禁忌や副作用があるため、イギリスでは処方箋が必要な薬である。イギリスの英国国民医薬品集(British National Formulary)では、掲載が中止されている。 アザプロパゾンの半減期は、ヒトでは約20時間であり、あまり代謝されない。
, آزابروبازون Azapropazone أو Rheumox هو مضاد التهاب لا ستيروئيدي يصرف بموجب وصفة طبية فقط، وذلك بسبب آثاره الجانبية والمحاذير الخاصة به. لم يعد يدرج ضمن . يملك نصف عمر حوالي 20ساعة، وهو لايستقلب بشكل كبير.
, Azapropazone is a nonsteroidal anti-inflam … Azapropazone is a nonsteroidal anti-inflammatory drug (NSAID). It is manufactured by under the tradename Rheumox. It was available in the UK as a prescription-only drug, with restrictions due to certain contra-indications and side-effects. Azopropazone has now been discontinued in the British National Formulary. Azapropazone has a half-life of approximately 20 hours in humans and is not extensively metabolized.humans and is not extensively metabolized.
, L'azapropazone è un farmaco antinfiammator … L'azapropazone è un farmaco antinfiammatorio non steroideo (FANS) dotato di proprietà analgesiche e antipiretiche. La molecola possiede una debole azione di inibizione della cicloossigenasi, ma dimostra una spiccata attività uricosurica, pertanto in passato venne ampiamente utilizzata per il trattamento della gotta acuta. L'azapropazone è stato anche utilizzato per il trattamento dell'artrite reumatoide, della spondilite anchilosante e dell'osteoartrite.ondilite anchilosante e dell'osteoartrite.
, Apazona ou azapropazona é um fármaco da cl … Apazona ou azapropazona é um fármaco da classe terapêutica dos AINEs. Possui atividades anti-inflamatórias, antipiréticas e analgésicas, apesar de ser um inibidor pouco potente da ciclooxigenase. Medicamentos com este princípio ativo são utilizados no tratamento da gota, artrite reumatóide e osteoartrite. Apesar de sua menor atividade em relação aos outros fármacos do mesmo grupo, as precauções pertinentes ao seu uso são as mesmas.ções pertinentes ao seu uso são as mesmas.
|
| http://dbpedia.org/ontology/alternativeName
|
Rheumox
|
| http://dbpedia.org/ontology/casNumber
|
13539-59-8
|
| http://dbpedia.org/ontology/chEBI
|
38010
|
| http://dbpedia.org/ontology/chEMBL
|
1231131
|
| http://dbpedia.org/ontology/fdaUniiCode
|
K2VOT966ZI
|
| http://dbpedia.org/ontology/kegg
|
D02966
|
| http://dbpedia.org/ontology/pubchem
|
26098
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/azapropazone.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
13590530
|
| http://dbpedia.org/ontology/wikiPageLength
|
3582
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1082241275
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Nonsteroidal_anti-inflammatory_drug +
, http://dbpedia.org/resource/Category:Lactams +
, http://dbpedia.org/resource/Category:Nonsteroidal_anti-inflammatory_drugs +
, http://dbpedia.org/resource/Prescription_medication +
, http://dbpedia.org/resource/Category:Triazines +
, http://dbpedia.org/resource/Goldshield +
, http://dbpedia.org/resource/British_National_Formulary +
, http://dbpedia.org/resource/Racemic_mixture +
|
| http://dbpedia.org/property/alt
|
Azapropazone molecule
|
| http://dbpedia.org/property/atcPrefix
|
M01
|
| http://dbpedia.org/property/atcSuffix
|
AX04
|
| http://dbpedia.org/property/c
|
16
|
| http://dbpedia.org/property/casNumber
|
13539
|
| http://dbpedia.org/property/chebi
|
38010
|
| http://dbpedia.org/property/chembl
|
1231131
|
| http://dbpedia.org/property/chemspiderid
|
24310
|
| http://dbpedia.org/property/chirality
|
http://dbpedia.org/resource/Racemic_mixture +
|
| http://dbpedia.org/property/eliminationHalfLife
|
72000.0
|
| http://dbpedia.org/property/h
|
20
|
| http://dbpedia.org/property/image
|
Azapropazone 3D spacefill.png
|
| http://dbpedia.org/property/iupacName
|
-5
|
| http://dbpedia.org/property/kegg
|
D02966
|
| http://dbpedia.org/property/legalUk
|
POM
|
| http://dbpedia.org/property/n
|
4
|
| http://dbpedia.org/property/o
|
2
|
| http://dbpedia.org/property/pubchem
|
26098
|
| http://dbpedia.org/property/smiles
|
O=C3N/1NCC3CCC
|
| http://dbpedia.org/property/stdinchi
|
1
|
| http://dbpedia.org/property/stdinchikey
|
MPHPHYZQRGLTBO-UHFFFAOYSA-N
|
| http://dbpedia.org/property/tradename
|
Rheumox
|
| http://dbpedia.org/property/unii
|
K2VOT966ZI
|
| http://dbpedia.org/property/verifiedfields
|
changed
|
| http://dbpedia.org/property/verifiedrevid
|
477351400
|
| http://dbpedia.org/property/watchedfields
|
changed
|
| http://dbpedia.org/property/width
|
200
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Anti-inflammatory_and_antirheumatic_products +
, http://dbpedia.org/resource/Template:Analgesics +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Prostanoidergics +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Drugs.com +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Stdinchicite +
, http://dbpedia.org/resource/Template:Drugbankcite +
, http://dbpedia.org/resource/Template:Cascite +
, http://dbpedia.org/resource/Template:Chemspidercite +
, http://dbpedia.org/resource/Template:Ebicite +
, http://dbpedia.org/resource/Template:Musculoskeletal-drug-stub +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Keggcite +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Lactams +
, http://dbpedia.org/resource/Category:Nonsteroidal_anti-inflammatory_drugs +
, http://dbpedia.org/resource/Category:Triazines +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Drug +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Azapropazone?oldid=1082241275&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Azapropazone_3D_spacefill.png +
, http://commons.wikimedia.org/wiki/Special:FilePath/azapropazone.svg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Azapropazone +
|
| owl:sameAs |
http://yago-knowledge.org/resource/Azapropazone +
, http://pt.dbpedia.org/resource/Apazona +
, http://dbpedia.org/resource/Azapropazone +
, http://ro.dbpedia.org/resource/Azapropazon%C4%83 +
, https://global.dbpedia.org/id/3Q4Lg +
, http://rdf.freebase.com/ns/m.03cb97q +
, http://ar.dbpedia.org/resource/%D8%A2%D8%B2%D8%A7%D8%A8%D8%B1%D9%88%D8%A8%D8%A7%D8%B2%D9%88%D9%86 +
, http://vi.dbpedia.org/resource/Azapropazone +
, http://www.wikidata.org/entity/Q368222 +
, http://ja.dbpedia.org/resource/%E3%82%A2%E3%82%B6%E3%83%97%E3%83%AD%E3%83%91%E3%82%BE%E3%83%B3 +
, http://it.dbpedia.org/resource/Azapropazone +
, http://sh.dbpedia.org/resource/Azapropazon +
, http://azb.dbpedia.org/resource/%D8%A2%D8%B2%D8%A7%D9%BE%D8%B1%D9%88%D9%BE%D8%A7%D8%B2%D9%88%D9%86 +
, http://sr.dbpedia.org/resource/Azapropazon +
, http://fa.dbpedia.org/resource/%D8%A2%D8%B2%D8%A7%D9%BE%D8%B1%D9%88%D9%BE%D8%A7%D8%B2%D9%88%D9%86 +
|
| rdf:type |
http://dbpedia.org/class/yago/Communication100033020 +
, http://dbpedia.org/class/yago/WikicatMolecularFormulas +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/class/yago/MolecularFormula106817173 +
, http://dbpedia.org/class/yago/Message106598915 +
, http://dbpedia.org/class/yago/Formula106816935 +
, http://dbpedia.org/class/yago/AliphaticCompound114601294 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/class/yago/Alkene114713120 +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://dbpedia.org/class/yago/Relation100031921 +
, http://dbpedia.org/class/yago/WikicatAlkenes +
, http://umbel.org/umbel/rc/DrugProduct +
, http://dbpedia.org/class/yago/Part113809207 +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/class/yago/WikicatTriazines +
, http://dbpedia.org/class/yago/Triazine115079030 +
, http://dbpedia.org/class/yago/Statement106722453 +
, http://dbpedia.org/class/yago/Matter100020827 +
, http://dbpedia.org/class/yago/OrganicCompound114727670 +
, http://dbpedia.org/class/yago/Material114580897 +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/class/yago/Compound114818238 +
, http://dbpedia.org/class/yago/Chemical114806838 +
, http://dbpedia.org/class/yago/Substance100019613 +
|
| rdfs:comment |
Apazona ou azapropazona é um fármaco da cl … Apazona ou azapropazona é um fármaco da classe terapêutica dos AINEs. Possui atividades anti-inflamatórias, antipiréticas e analgésicas, apesar de ser um inibidor pouco potente da ciclooxigenase. Medicamentos com este princípio ativo são utilizados no tratamento da gota, artrite reumatóide e osteoartrite. Apesar de sua menor atividade em relação aos outros fármacos do mesmo grupo, as precauções pertinentes ao seu uso são as mesmas.ções pertinentes ao seu uso são as mesmas.
, آزابروبازون Azapropazone أو Rheumox هو مضاد التهاب لا ستيروئيدي يصرف بموجب وصفة طبية فقط، وذلك بسبب آثاره الجانبية والمحاذير الخاصة به. لم يعد يدرج ضمن . يملك نصف عمر حوالي 20ساعة، وهو لايستقلب بشكل كبير.
, L'azapropazone è un farmaco antinfiammator … L'azapropazone è un farmaco antinfiammatorio non steroideo (FANS) dotato di proprietà analgesiche e antipiretiche. La molecola possiede una debole azione di inibizione della cicloossigenasi, ma dimostra una spiccata attività uricosurica, pertanto in passato venne ampiamente utilizzata per il trattamento della gotta acuta. L'azapropazone è stato anche utilizzato per il trattamento dell'artrite reumatoide, della spondilite anchilosante e dell'osteoartrite.ondilite anchilosante e dell'osteoartrite.
, Azapropazone is a nonsteroidal anti-inflam … Azapropazone is a nonsteroidal anti-inflammatory drug (NSAID). It is manufactured by under the tradename Rheumox. It was available in the UK as a prescription-only drug, with restrictions due to certain contra-indications and side-effects. Azopropazone has now been discontinued in the British National Formulary. Azapropazone has a half-life of approximately 20 hours in humans and is not extensively metabolized.humans and is not extensively metabolized.
, アザプロパゾン(Azapropazone)は、Goldshield社がRheumoxの商標名で製造する非ステロイド性抗炎症薬である。 禁忌や副作用があるため、イギリスでは処方箋が必要な薬である。イギリスの英国国民医薬品集(British National Formulary)では、掲載が中止されている。 アザプロパゾンの半減期は、ヒトでは約20時間であり、あまり代謝されない。
|
| rdfs:label |
آزابروبازون
, アザプロパゾン
, Apazona
, Azapropazone
|
